Immunovia is a diagnostic company that develops high-accuracy blood tests for early detection of cancer and autoimmune diseases, based on the inhouse developed and proprietary test platform: IMMray™.
The breakthrough product, IMMray™ PanCan-d – a blood-based test developed for the unmet need of early and accurate detection of pancreatic cancer (PDAC) – will be commercially launched in the United States in the fourth quarter 2020. This will be followed by a European roll-out of IMMray™ PanCan-d and, subsequently, in other markets.
Immunovia Dx Laboratories located in Marlborough, Massachusetts, USA and Lund, Sweden will provide laboratory testing services in two accredited reference laboratories.
Join us. Join Immunovia WALK for awareness of pancreatic cancer.